MLPA® Kits

For a description how to create and adapt MLPA Kits, that are not available on this page, please have a look at our User Manual MLPA.

Import of SALSA MLPA® kit descriptions via the SEQUENCE Pilot operation "Mixes [master file] / button [Import]".

Mix
Version
Date
Region
Application
Vs. 10
25-08-2011
MYBPC3 11p11.2 Hypertrophic cardiomyopathy, familial
P100-C1 Vs. 11 16-03-2012 MYBPC3 11p11.2 Hypertrophic cardiomyopathy, familial
P100-C1 Vs.12 21-12-2012 MYBPC3 11p11.2 Hypertrophic cardiomyopathy, familial
P100-C1 Vs.14 25-11-2015 MYBPC3 11p11.2 Hypertrophic cardiomyopathy, familial
P100-C1 Vs.15 13-09-2016 MYBPC3 11p11.2 Hypertrophic cardiomyopathy, familial
Vs. 17
01-03-2013
STK11 19p13.3 Peutz-jeghers syndrome (PJS)
Vs. 19
29-09-2014
STK11 19p13.3 Peutz-jeghers syndrome (PJS)
P101-B2 Vs. 20 04-06-2015 STK11 19p13.3 Peutz-jeghers syndrome (PJS)
P101-B3 Vs. 21 14-01-2016 STK11 19p13.3 Peutz-jeghers syndrome (PJS)
P101-B4 Vs. B4-02 13-06-2017 STK11 19p13.3 Peutz-jeghers syndrome (PJS)
P102-B2 Vs.16 19-10-2012 HBB 11p15.5 Thalassemia, beta-zero
P102-B2 Vs.17 21-12-2012 HBB 11p15.5 Thalassemia, beta-zero
P102-B2 Vs.19 17-09-2013 HBB 11p15.5 Thalassemia, beta-zero
P102-B2 Vs.20 10-07-2014 HBB 11p15.5 Thalassemia, beta-zero
P102-C1 Vs.22 15-10-2014 HBB 11p15.5 Thalassemia, beta-zero
P102-C1 Vs.23 19-11-2014 HBB 11p15.5 Thalassemia, beta-zero
P102-C1 Vs.25 24-11-2015 HBB 11p15.5 Thalassemia, beta-zero
P102-C1 Vs.27 20-09-2016 HBB 11p15.5 Thalassemia, beta-zero
P102-C1 Vs.28 03-04-2017 HBB 11p15.5 Thalassemia, beta-zero
P102-C1 Vs.29 28-04-2017 HBB 11p15.5 Thalassemia, beta-zero
Vs. 06
23-07-2008
DPYD 1p22 Dihydropyrimidine dehydrogenase (DPYD) deficiency
Vs. 09
24-08-2011
DPYD 1p22 Dihydropyrimidine dehydrogenase (DPYD) deficiency
Vs. 12
30-08-2016
DPYD 1p22 Dihydropyrimidine dehydrogenase (DPYD) deficiency
Vs. 09
02-09-2011
ATP7A Xq13.3 Menkes disease
P104-B2 Vs. 10 22-06-2012 ATP7A Xq13.3 Menkes disease
P104-B2 Vs. 12 23-02-2015 ATP7A Xq13.3 Menkes disease
P104-C1 Vs. 13 14-12-2016 ATP7A Xq13.3 Menkes disease
Vs. 13
20-11-2008
EGFR, TP53, PTEN, CDKN2A, ERBB2 Oligodendroglioma
Vs. 19
25-08-2011
EGFR, TP53, PTEN, CDKN2A, ERBB2 Oligodendroglioma
Vs. 11
18-07-2009
Chromosome X Mental retardation, x-linked (XLMR)
P106-B1 Vs. 13 25-08-2011 Chromosome X Mental retardation, x-linked (XLMR)
P106-B1 Vs. 14 03-12-2012 Chromosome X Mental retardation, x-linked (XLMR)
P106-B2 Vs. 15 21-03-2013 Chromosome X Mental retardation, x-linked (XLMR)
P106-B2 Vs. 16 26-09-2014 Chromosome X Mental retardation, x-linked (XLMR)
P106-B2 Vs. 17 29-02-2016 Chromosome X Mental retardation, x-linked (XLMR)
P106-C1 Vs. 18 30-09-2016 Chromosome X Mental retardation, x-linked (XLMR)
Vs. 03
11-06-2008
ASPA, MLC1, MLYCD, D2HGDH, L2HGDH Neurometabolic disorders
Vs. 05
25-08-2011
ASPA, MLC1, MLYCD, D2HGDH, L2HGDH Neurometabolic disorders
Vs. 06
23-02-2013
ASPA, MLC1, MLYCD, D2HGDH, L2HGDH Neurometabolic disorders
Vs. 07
22-07-2015
ASPA, MLC1, MLYCD, D2HGDH, L2HGDH Neurometabolic disorders
Vs. 08
10-05-2016
ASPA, MLC1, MLYCD, D2HGDH, L2HGDH Neurometabolic disorders
Vs. 08
27-05-2010
SCN5A 3p22 Brugada / long QT
P108-B2 Vs. 10 14-05-2012 SCN5A 3p22 Brugada / long QT
P108-B2 Vs. 11 15-02-2012 SCN5A 3p22 Brugada / long QT
P108-B2 Vs. 12 23-07-2015 SCN5A 3p22 Brugada / long QT
P108-B3 Vs. 13 11-10-2016 SCN5A 3p22 Brugada / long QT
Vs. 08
13-10-2010
ABCB4 7q21,1 Drug-transport pump
Vs. 09
31-08-2011
ABCB4 7q21,1 Drug-transport pump
Vs. 10
03-12-2012
ABCB4 7q21,1 Drug-transport pump
Vs. 11
15-02-2013
ABCB4 7q21,1 Drug-transport pump
Vs. 12
22-07-2015
ABCB4 7q21,1 Drug-transport pump
Vs. 13
24-08-2016
ABCB4 7q21,1 Drug-transport pump
Vs. 08
29-10-2010
PROS1 3q11.2 PROS1 deficiency
Vs. 10
01-09-2011
PROS1 3q11.2 PROS1 deficiency
Vs. 11
03-12-2012
PROS1 3q11.2 PROS1 deficiency
Vs. 12
16-04-2013
PROS1 3q11.2 PROS1 deficiency
Vs. 13
26-09-2014
PROS1 3q11.2 PROS1 deficiency
Vs. 14
28-09-2016
PROS1 3q11.2 PROS1 deficiency
Vs. 05
12-06-2008
FANCB Xp22 Fanconi anemia complementation group B
Vs. 08
01-09-2011
FANCB Xp22 Fanconi anemia complementation group B
Vs. 11
28-10-2015
FANCB Xp22 Fanconi anemia complementation group B
Vs. 12
10-01-2017
FANCB Xp22 Fanconi anemia complementation group B
Vs. 13
07-06-2017
FANCB Xp22 Fanconi anemia complementation group B
Vs. 15
02-09-2011
KCNQ1 11p15.5, KCNH2 7q35 LQT
P114-B1 Vs. 16 12-07-2012 KCNQ1 11p15.5, KCNH2 7q35 LQT
P114-B1 Vs. 17 03-12-2012 KCNQ1 11p15.5, KCNH2 7q35 LQT
P114-B2 Vs. 18 03-02-2014 KCNQ1 11p15.5, KCNH2 7q35 LQT
P114-B2 Vs. 19 03-03-2016 KCNQ1 11p15.5, KCNH2 7q35 LQT
P114-B3 Vs. 20 01-06-2017 KCNQ1 11p15.5, KCNH2 7q35 LQT
Vs. 05
19-01-2012
SGCA, SGCB, SGCD, SGCG, FKRP Limb-girdle muscular dystrophy (LGMD)
P116-B1 Vs. 08 22-07-2015 SGCA, SGCB, SGCD, SGCG, FKRP Limb-girdle muscular dystrophy (LGMD)
Vs. 01
15-07-2008
ABCC8 11p15.1 HHF1
Vs. 02
18-10-2010
ABCC8 11p15.1 HHF1
Vs. 05
29-11-2013
ABCC8 11p15.1 HHF1
Vs. 06
13-02-2017
ABCC8 11p15.1 HHF1
P118-C1 Vs. 04
03-12-2012
WT1 11p13 Wilms tumours, WAGR, Denys-Drash, Frasier syndrome
P118-C1 Vs. 05
13-06-2014
WT1 11p13 Wilms tumours, WAGR, Denys-Drash, Frasier syndrome
P118-C2 Vs. 06 20-01-2015 WT1 11p13 Wilms tumours, WAGR, Denys-Drash, Frasier syndrome
Vs. 07
23-09-2009
RHD 1p36.2-1p34 Rh blood group antigens